GENI Long Call Strategy
GENI (Genius Sports Limited), in the Communication Services sector, (Internet Content & Information industry), listed on NYSE.
Genius Sports Limited, based in London, United Kingdom, delivers advanced technology solutions and specialized services to stakeholders across the sports, sports betting, and sports media sectors. The company provides crucial technological infrastructure for the comprehensive management of live sports data, including its collection, seamless integration, and broad distribution. It also equips sports organizations with streaming capabilities, offering the necessary technology, automated production, and distribution pathways to monetize their game footage. A key offering is its extensive integrity services designed for sports leagues, which involve continuous, active monitoring technology employing sophisticated mathematical algorithms to detect and flag suspicious wagering patterns in global betting markets. These services are further supported by a complete suite of online and in-person educational and advisory programs. Beyond these core services, Genius Sports facilitates the acquisition of live sports data and supplies both pre-game and in-game odds feeds.
GENI (Genius Sports Limited) trades in the Communication Services sector, specifically Internet Content & Information, with a market capitalization of approximately $1.60B, a beta of 1.92 versus the broader market, a 52-week range of 3.825-13.73, average daily share volume of 6.1M, a public-listing history dating back to 2020, approximately 2K full-time employees. These structural characteristics shape how GENI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.92 indicates GENI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on GENI?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current GENI snapshot
As of June 30, 2026, spot at $6.06, ATM IV 82.80%, IV rank 32.89%, expected move 23.74%. The long call on GENI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long call structure on GENI specifically: GENI IV at 82.80% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 23.74% (roughly $1.44 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GENI expiries trade a higher absolute premium for lower per-day decay. Position sizing on GENI should anchor to the underlying notional of $6.06 per share and to the trader's directional view on GENI stock.
GENI long call setup
The GENI long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GENI near $6.06, the first option leg uses a $6.06 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GENI chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GENI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $6.06 | N/A |
GENI long call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
GENI long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on GENI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long call on GENI
Long calls on GENI express a bullish thesis with defined risk; traders use them ahead of GENI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
GENI thesis for this long call
The market-implied 1-standard-deviation range for GENI extends from approximately $4.62 on the downside to $7.50 on the upside. A GENI long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current GENI IV rank near 32.89% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on GENI should anchor more to the directional view and the expected-move geometry. As a Communication Services name, GENI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GENI-specific events.
GENI long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GENI positions also carry Communication Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GENI alongside the broader basket even when GENI-specific fundamentals are unchanged. Long-premium structures like a long call on GENI are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current GENI chain quotes before placing a trade.
Frequently asked questions
- What is a long call on GENI?
- A long call on GENI is the long call strategy applied to GENI (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With GENI stock trading near $6.06, the strikes shown on this page are snapped to the nearest listed GENI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are GENI long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the GENI long call priced from the end-of-day chain at a 30-day expiry (ATM IV 82.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GENI long call?
- The breakeven for the GENI long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GENI market-implied 1-standard-deviation expected move is approximately 23.74%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on GENI?
- Long calls on GENI express a bullish thesis with defined risk; traders use them ahead of GENI catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current GENI implied volatility affect this long call?
- GENI ATM IV is at 82.80% with IV rank near 32.89%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.